Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Peifer

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
NPJ Precision Oncology|December 18, 2021
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancerDiana Schaufler, David F Ast, Hannah L Tumbrink, et al.
The Journal of Pathology|July 21, 2017
Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndromeHans Binder, Lydia Hopp, Michal R Schweiger, et al.
Cell|January 8, 2019
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive TumorsRon D Jachimowicz, Filippo Beleggia, Jörg Isensee, et al.
Blood|April 23, 2026
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesisKristie Tanavura Bariboloka, Santiago Serrano-Saenz, Deniz Pinar Savcigil, et al.
Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.
Cancer Discovery|December 5, 2013
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancerFlorian Malchers, Felix Dietlein, Jakob Schöttle, et al.
Nature Genetics|June 30, 2015
Mutational dynamics between primary and relapse neuroblastomasAlexander Schramm, Johannes Köster, Yassen Assenov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2015
Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer PatientsKatharina König, Martin Peifer, Jana Fassunke, et al.
Cell Reports|September 21, 2017
Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline CarcinomaJohannes Brägelmann, Marcel A Dammert, Felix Dietlein, et al.
Cancer Cell|January 17, 2017
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase InhibitionGurkan Mollaoglu, Matthew R Guthrie, Stefanie Böhm, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
NPJ Precision Oncology|December 18, 2021
Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancerDiana Schaufler, David F Ast, Hannah L Tumbrink, et al.
The Journal of Pathology|July 21, 2017
Genomic and transcriptomic heterogeneity of colorectal tumours arising in Lynch syndromeHans Binder, Lydia Hopp, Michal R Schweiger, et al.
Cell|January 8, 2019
UBQLN4 Represses Homologous Recombination and Is Overexpressed in Aggressive TumorsRon D Jachimowicz, Filippo Beleggia, Jörg Isensee, et al.
Blood|April 23, 2026
Expression of cFLIP in B cells is essential for diffuse large B-cell lymphoma pathogenesisKristie Tanavura Bariboloka, Santiago Serrano-Saenz, Deniz Pinar Savcigil, et al.
Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.
Cancer Discovery|December 5, 2013
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancerFlorian Malchers, Felix Dietlein, Jakob Schöttle, et al.
Nature Genetics|June 30, 2015
Mutational dynamics between primary and relapse neuroblastomasAlexander Schramm, Johannes Köster, Yassen Assenov, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2015
Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer PatientsKatharina König, Martin Peifer, Jana Fassunke, et al.
Cell Reports|September 21, 2017
Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline CarcinomaJohannes Brägelmann, Marcel A Dammert, Felix Dietlein, et al.
Cancer Cell|January 17, 2017
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase InhibitionGurkan Mollaoglu, Matthew R Guthrie, Stefanie Böhm, et al.
Pageof 11